Piramal Enterprises has received approval for issuance of up to Rs 1000 crore Secured, Rated, Unlisted, Redeemable Non-Convertible Debentures (NCDs) on private placement basis. The meeting of Administrative Committee of the Board of Directors held on November 07, 2022 approved the same.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.